Neurobiological basis for the use of botulinum toxin in pain therapy.
about
OnabotulinumtoxinA for trigeminal neuralgia: a review of the available dataBotulinum Toxin for Neuropathic Pain: A Review of the LiteratureBotulinum Toxin as a Pain Killer: Players and Actions in AntinociceptionBotulinum Toxin Type A for the Treatment of Neuropathic Pain in Neuro-RehabilitationBotulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerationsBotulinum as a Toxin for Treating Post-herpetic NeuralgiaA critical evaluation of migraine trigger site deactivation surgery.Arthritis and pain. Future targets to control osteoarthritis painBotulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.Critical analysis of the use of onabotulinumtoxinA (botulinum toxin type A) in migraine.A review of thoracic outlet syndrome and the possible role of botulinum toxin in the treatment of this syndromeBotulinum toxin for the treatment of myofascial pain syndromes involving the neck and back: a review from a clinical perspectiveBotulinum Toxin A Injection into the Subscapularis Muscle to Treat Intractable Hemiplegic Shoulder Pain.Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal NeuralgiaCentral nervous system toxicity after botulinum neurotoxin injectionBotulinum toxin for pelvic pain in women.Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.Microstructural Abnormalities Were Found in Brain Gray Matter from Patients with Chronic Myofascial Pain.Efficacy of intraarticular botulinum toxin A and intraarticular hyaluronate plus rehabilitation exercise in patients with unilateral ankle osteoarthritis: a randomized controlled trial.Use of botulinum toxin for chronic pelvic pain.Targeted biological therapies for pain.Botulinum neurotoxin for pain management: insights from animal models.Headache Attributed to Craniocervical Dystonia - A Little Known Headache.Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.Is lateral epicondylitis a new indication for botulinum toxin?A comparison of the short-term effects of a botulinum toxin type a and triamcinolone acetate injection on adhesive capsulitis of the shoulder.Reduction of adhesion formation after knee surgery in a rat model by botulinum toxin A.A direct inhibitory effect of botulinum toxin type A on antral circular muscle contractility of guinea pig.Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up.Effect of lidocaine patches on upper trapezius EMG activity and pain intensity in patients with myofascial trigger points: A randomized clinical study.
P2860
Q26796286-EDBA4E62-9B44-4BE7-A759-E594EA5C1645Q26796604-55319BFB-9AB7-4FA6-85CB-BCCBC4028B08Q28084583-9DE11CAF-A7AF-4B5C-9965-82BABF5D4416Q28088625-3B82ED5E-2C71-489B-B1BE-05A35C5631A7Q28194984-0C719729-020C-42BB-952A-813B572B120AQ33720660-4F09667A-8ACC-450C-B868-8A50ABE49666Q34377127-734D67A5-3090-49CD-BAEC-FD221B313331Q34636446-9C337EB3-D18F-43F8-876E-5459461BFD01Q34785937-0C067D2A-87CD-4C22-BBB7-FA296F2E47DDQ35681903-E7E35957-AD3C-4F75-A2D7-968D6682337CQ36432805-F0C842CF-9C17-4DCE-913C-EDC377625E6AQ36663947-617989B6-2A2F-42E5-981F-41CF6733BD74Q37235422-A441A54B-67D3-462F-AA0A-C06A6CEBDD36Q37250488-CE03A126-3959-43BD-93EF-DEDF48707C9EQ37289991-04E9A4BE-A43F-40C5-8197-8AF940555560Q37346181-56CE4CAE-0377-4E76-8A88-A388C6C87B4CQ37457570-1026D23F-D02B-41A1-92BC-A5716CE8640DQ37516112-84847D78-7918-4BE0-B769-1B731E1F0AA9Q37580384-05D25EA9-D326-4206-A2CD-EA075FF7DBF6Q37741760-659F5C4F-6939-4E3C-8E30-C4DE2D2B6293Q37882724-8CFF265B-BA18-404A-BF85-B4B47110FB9EQ37954278-B467C5D2-3B00-43BA-A204-3C6947E74305Q39026792-2335297B-2299-4C63-B046-E813AD139642Q40561965-50BE876F-2270-4D59-979C-EEC657957680Q40594492-9D62C1D7-ED38-4EFD-9BB5-8A29D8E006FCQ40907188-66787AFB-D0FE-4CDA-9479-05BF4CC69300Q41962174-6E630F45-7616-421E-9D87-2884228E5E3EQ42218964-17826EF6-5F3F-475B-A776-7097DDFF69CFQ42283406-839AC433-B34E-4863-B798-DF4737B8B6C8Q47786013-89FFF525-B2D8-437D-911E-DD2D3AF91F7B
P2860
Neurobiological basis for the use of botulinum toxin in pain therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Neurobiological basis for the use of botulinum toxin in pain therapy.
@ast
Neurobiological basis for the use of botulinum toxin in pain therapy.
@en
type
label
Neurobiological basis for the use of botulinum toxin in pain therapy.
@ast
Neurobiological basis for the use of botulinum toxin in pain therapy.
@en
prefLabel
Neurobiological basis for the use of botulinum toxin in pain therapy.
@ast
Neurobiological basis for the use of botulinum toxin in pain therapy.
@en
P1433
P1476
Neurobiological basis for the use of botulinum toxin in pain therapy.
@en
P2093
P2888
P356
10.1007/S00415-004-1102-Z
P478
251 Suppl 1
P577
2004-02-01T00:00:00Z